Covid: dispute over the paternity of the vaccine between Moderna and the US government

Posted on Nov 10, 2021 at 6:01 amUpdated Nov 10, 2021, 7:15 AM

An intellectual property dispute could well threaten the distribution of part of future Covid vaccines. The “New York Times” revealed that Moderna and the US government are currently arguing over the authorship of an essential component of the company’s vaccine. The National Institutes of Health (NIH) says three of its scientists, John Mascola, Barney Graham and Kizzmekia Corbett, worked with Cambridge biotech to design the genetic sequence that prompts the vaccine to produce an immune response. And, for that, they “should be cited on the main patent application”.

For Moderna, this is out of the question. In a statement to the Patent and Trademark Office in July, the company headed by Frenchman Stéphane Bancel exclusively cited several of its employees as the inventors of the component.

Leave a Reply

Your email address will not be published. Required fields are marked *